FGAM
SUPN icon

Financial Gravity Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Financial Gravity Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$24 – 2042
2023
Q4 		$24 Hold
1
– – ﹤0.01% 1420
2023
Q3 		$24 Sell
1
-29
-97% -$883 ﹤0.01% 1122
2023
Q2 		$629 Buy
+30
New +$1.05K ﹤0.01% 950
2022
Q2 		– Sell
-576
Closed -$2.9K – 838
2022
Q1 		$2.9K Buy
+576
New +$17.7K 0.08% 215
2021
Q3 		– Sell
-104
Closed -$31K – 1001
2021
Q2 		$31K Sell
104
-17
-14% -$521 0.01% 706
2021
Q1 		$3.17K Buy
+121
New +$3.38K 0.06% 191
2019
Q4 		– Sell
-16
Closed – – 1680
2019
Q3 		$0 Buy
16
+4
+33% +$119 ﹤0.01% 1530
2019
Q2 		$0 Sell
12
-1,209
-99% -$41.4K ﹤0.01% 1639
2019
Q1 		$44K Buy
+1,221
New +$45.4K 0.04% 343
2018
Q3 		$2K Sell
47
-11
-19% -$543 ﹤0.01% 1004
2018
Q2 		$3K Buy
58
+30
+107% +$1.55K ﹤0.01% 912
2018
Q1 		$1K Buy
+28
New +$1.17K ﹤0.01% 1260

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Financial Gravity Asset Management's SUPN Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2024, closing a stake of 1 share — an estimated $24 sold.

Financial Gravity Asset Management first reported a position in SUPN in Q1 2018 and held it in 12 quarters. The position peaked at $44K in Q1 2019. 250 funds tracked by Wall St. Rank hold SUPN as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining Supernus Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 1 Supernus Pharmaceuticals share in Q1 2024, an estimated $24.
  • Financial Gravity Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2018 and held it in 12 quarters.
  • Financial Gravity Asset Management's Supernus Pharmaceuticals position peaked at $44K in Q1 2019.
  • 250 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.